Development of an Anticancer Fungal Paclitaxel-Loaded Hydrogel System via 3D Bioprinting: A Next-Generation Biomedical Platform

利用3D生物打印技术开发抗癌真菌紫杉醇负载水凝胶系统:下一代生物医学平台

阅读:2

Abstract

Paclitaxel (Taxol) is a widely used anticancer drug, but its limited natural availability necessitates alternative production strategies. In this study, Aspergillus flavus isolated from wastewater was identified as a source of paclitaxel, which was confirmed by chromatographic and spectroscopic analyses. To improve solubility and delivery, paclitaxel was incorporated into a three-dimensional bioprinted hydrogel composed of sodium alginate and hyaluronic acid. A 2:1 sodium alginate-to-hyaluronic acid ratio provided the most suitable formulation, as it balanced viscosity, stability, and printability. The resulting scaffolds exhibited uniform porosity and elastic recovery, supporting controlled drug release. Paclitaxel-loaded hydrogels showed significant cytotoxicity against breast cancer cells (IC(50) = 11.63 μg/mL) and inhibited cell migration. These findings demonstrate a sustainable microbial route for paclitaxel production and highlight the potential of bioprinted hydrogels for targeted, controlled anticancer therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。